Abstract
Rationale
Alteration in serum prolactin (PRL) levels may reflect changes in central dopamine activity, which modulates the behavioral effects of cocaine. Therefore, serum PRL may have a potential role as a biological marker of drug severity and treatment outcome in cocaine dependence.
Objective
We investigated whether serum PRL levels differed between cocaine-dependent (CD) subjects and controls, and whether PRL levels were associated with severity of drug use and treatment outcome in CD subjects.
Methods
Basal PRL concentrations were assayed in 141 African–American (AA) CD patients attending an outpatient treatment program and 60 AA controls. Severity of drug use was assessed using the Addiction Severity Index (ASI). Measures of abstinence and retention during 12 weeks of treatment and at 6-month follow-up were employed as outcome variables.
Results
The basal PRL (ng/ml) in CD patients (9.28±4.13) was significantly higher than controls (7.33±2.94) (t=3.77, P<0.01). At baseline, PRL was positively correlated with ASI-drug (r=0.38, P<0.01), ASI-alcohol (r=0.19, P<0.05), and ASI-psychological (r=0.25, P<0.01) composite scores, and with the quantity of cocaine use (r=0.18, P<0.05). However, PRL levels were not significantly associated with number of negative urine screens, days in treatment, number of sessions attended, dropout rate or changes in ASI scores during treatment and at follow-up. Also, basal PRL did not significantly contribute toward the variance in predicting any of the outcome measures.
Conclusion
Although cocaine use seems to influence PRL levels, it does not appear that PRL is a predictor of treatment outcome in cocaine dependence.
Similar content being viewed by others
References
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorder, 4th edn. American Psychiatric Association, Washington D.C.
Appleberg B, Katila H, Rimon R (2000) Inverse correlation between hallucinations and serum prolactin in patients with non-affective psychoses. Schizophr Res 44:183–186
Basturk M, Karaaslan F, Esel E, Sofuoglu S, Tutus A, Yabanoglu I (2001) Effects of short and long-term lithium treatment on serum prolactin levels in patients with bipolar affective disorder. Prog Neuropsychopharmacol Biol Psychiatry 25:315–322
Baumann MH, Rothman RB (1993) Effects of acute and chronic cocaine on the activity of the tuberoinfundibular dopamine neurons in the rat. Brain Res 608:175–179
Baumann MH, Gendron TM, Becketts KM, Henningfield JE, Gorelick DA, Rothman RB (1995) Effects of intravenous cocaine on plasma cortisol and PRL in human cocaine abusers. Biol Psychiatry 38:751–755
Beck AT, Steer RA (1987) Beck depression inventory. The Psychological Corporation, Harcourt, Brace, Tex.
Carroll FL, Lewin AH, Boja JW, Kuhar MJ (1992) Cocaine receptor: biochemical characterization and structure activity relationships of cocaine analogues at the dopamine transporter. J Med Chem 35:969–981
Chakravarty I, Sreedhar R, Ghosh KK, Card D, Bulusu S (1982) Circulating gonadotropin profile in severe cases of protein calorie malnutrition. Fertil Steril 37:650–654
Cocores JA, Dackis CA, Gold MS (1986) Sexual dysfunction secondary to cocaine abuse in two patients. J Clin Psychol 47:384–385
Dackis CA, Gold MS (1985) New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev 9:469–477
Eiler K, Schaefer MR, Salstrom D, Lowery R (1995) Double-blind comparison of bromocriptine and placebo in cocaine withdrawal. Am J Drug Alcohol Abuse 21:65–79
Fagerstrom KO, Schneider NF (1989) Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 12:159–182
First MB, Spitzer RL, Gibbon M, Williams JBW (1997) Structured clinical interview for DSM-IV disorders (SCID-IV). American Psychiatric Association, Washington D.C.
Fishbein DH, Lozovosky D, Jaffe JH (1989) Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers. Biol Psychiatry 25:1049–1066
Gawin FH, Kleber HD (1985) Neuroendocrine findings in chronic cocaine abusers: a preliminary report. Br J Psychiatry 147:569–573
Heatherton TK, Kozlowski LT, Frecker RC (1991) The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86:1119–1127
Joyce PR, Fergusson DM, Woollard G, Abbott RM, Horwood LJ, Upton J (1995) Urinary catecholamines and plasma hormones predict mood state in rapid cycling bipolar affective disorder. J Affect Disord 33:233–243
Komorowski J, Jankiewicz-Wilka J, Stepien H (2000) Effects of Gn-RH, TRH, and CRF administration on plasma leptin levels in lean and obese women. Neuropeptides 34:89–97
Koob GF, Caine B, Markou A, Pulvirenti L, Weiss F (1994) Role for the mesocortical dopamine system in the motivating effects of cocaine. NIDA Res Monogr 145:1–18
Kosten TR, Morgan CM, Falcione J, Scottenfeld RS (1992) Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantidine or desipramine. Arch Gen Psychiatry 49:894–898
Kranzler HR, Wallington DJ (1992) Serum PRL level, craving, and early discharge from treatment in cocaine-dependent patients. Am J Drug Alcohol Abuse 18:187–195
Kuhar MJ, Ritz MC, Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299–302
Levy AD, Baumann MH, Van de Kar LD (1994) Monoaminergic regulation of neuroendocrine function and its modification by cocaine. Front Neuroendocrinol 15:85–166
Martin JB, Reichlin S, Brown GM (1987) Regulation of PRL secretion and its disorders. In: Martin JB, Reichlin S (eds) Clinical neuroendocrinology. FA Davis, Philadelphia, pp 201–220
McDougle CJ, Price LH, Palumbo JM, Kosten TR, Henniger GR, Kleber HD (1992) Dopaminergic responsivity during cocaine abstinence: a pilot study. Psychiatry Res 43:77–85
McLellan AT, Luborsky L, Cacciola J, Griffith J, Evans F, Barr HL, O’Brien CP (1985) New data from the Addiction Severity Index: reliability and validity in three centers. J Nerv Ment Dis 173:412–423
McLellan AT, Luborsky L, Cacciola J, Kushner H, Peters L, Smith I, Pettinati H (1992) The fifth edition of the Addiction Severity Index: cautions, additions and normative data. J Nerv Ment Dis 168:26–33
Mello NK, Mendelson JH (1997) Cocaine’s effects on neuroendocrine systems: clinical and preclinical studies. Pharmacol Biochem Behav 57:571–599
Mendelson JH, Siew KT, Lange U, Mello NK, Weiss R, Skupny A, Ellingboe J (1988) Anterior pituitary, adrenal, and gonadal hormones during cocaine withdrawal. Am J Psychiatry 145:1094–1098
Miles LE, Lipschitz DA, Bieber CP, Cook JD (1974) Measurement of serum ferritin by a two-site immunoradiometric assay. Ann Biochem 61:209
Miller NS, Summers GL, Gold MS (1993) Cocaine dependence: alcohol and other drug dependence and withdrawal characteristics. J Addict Dis 12:25–35
Neill JD, Frawley LS, Plotsky PM, Tindall GI (1981) Dopamine in hypophysial stalk blood of the rhesus monkey and its role in regulating PRL secretion. Endocrinology 108:489–494
Nestler EJ (2001) Molecular neurobiology of addiction. Am J Addict 10:201–217
Nestler JF, Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278:58–63
Patkar AA, Hill KP, Sterling RC, Gottheil E, Berrettini WH, Weinstein SP (2002) Serum prolactin and response to treatment among cocaine-dependent individuals. Addict Biol 7:45–53
Satel SL, Price LH, Palumbo JM, McDougle CJ, Krystal JH, Gawin F, Charney DS, Heninger GR, Kleber HD (1991) Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. Am J Psychiatry 148:1712–1716
Swartz CM, Breen K, Leone F (1990) Serum PRL levels during extended cocaine abstinence. Am J Psychiatry 147:777–779
Teller DW, Devenyi P (1988) Bromocriptine in cocaine withdrawal—does it work? Int J Addict 23:1197–1205
Teoh SK, Mendelson JH, Mello NK, Weiss R, McElroy S, McAfee B (1990) Hyperprolactinemia and risk for relapse of cocaine abuse. Biol Psychiatry 28:824–828
Tuomisto J, Mannisto P (1985) Neurotransmitter regulation of anterior pituitary hormones. Pharmacol Rev 37:249–332
Weiss RD, Markou A, Lorang MT, Koob G (1992) Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited access self-administration. Brain Res 593:314–318
Weiss RD, Hufford C, Mendelson JH (1994) Serum PRL levels and treatment outcome in cocaine dependence. Biol Psychiatry 35:573–574
Acknowledgements
This research was supported in part by grants DA00340 and DA 015504 (A.A.P.) and DA11835 and DA14008 (W.H.B.) from the National Institute on Drug Abuse. The authors thank Cheryl Marshall for technical assistance and Stephen P. Weinstein for recruitment.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Patkar, A.A., Mannelli, P., Certa, K.M. et al. Relationship of serum prolactin with severity of drug use and treatment outcome in cocaine dependence. Psychopharmacology 176, 74–81 (2004). https://doi.org/10.1007/s00213-004-1856-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-004-1856-0